Research Structure Literature

"Prevention and Control of Avian Influenza in the U.S." Research Structure

• Introduction
• Accomplishments of AICAP 1
• Research Designs and Methods
• Specific Aims
• Literature Searched

LITERATURE SEARCHED

I. References

1. Akaike, T. 2001. Role of free radicals in viral pathogenesis and mutation. Rev Med Virol 11:87-101.

2. Alexander, D. J. 2000. A review of avian influenza in different bird species. Vet Microbiol 74:3-13.

3. Andral, B., D. Toquin, F. Madec, M. Aymard, J. M. Gourreau, C. Kaiser, M. Fontaine, and M. H. Metz. 1985. Disease in turkeys associated with H1N1 influenza virus following an outbreak of the disease in pigs. Vet Rec 116:617-8.

4. Anonymous 2002, posting date. Poultry: Production and Value, Annual Summary. National Agricultural Statistics Service, USDA. [Online.]

5. Aymard, M., A. R. Douglas, M. Fontaine, J. M. Gourreau, C. Kaiser, J. Million, and J. J. Skehel. 1985. Antigenic characterization of influenza A (H1N1) viruses recently isolated from pigs and turkeys in France. Bull World Health Organ 63:537-42.

6. Banker, C. A. 1980. Laboratory quality control: use of Shewhart charts and ANOVA. Am J Med Technol 46:274-9.

7. Birch-Machin, I., A. Rowan, J. Pick, J. Mumford, and M. Binns. 1997. Expression of the nonstructural protein NS1 of equine influenza A virus: detection of anti-NS1 antibody in post infection equine sera. J Virol Methods 65:255-63.

8. Bruns, K., N. Studtrucker, A. Sharma, T. Fossen, D. Mitzner, A. Eissmann, U. Tessmer, R. Roder, P. Henklein, V. Wray, and U. Schubert. 2007. Structural characterization and oligomerization of PB1-F2, a proapoptotic influenza A virus protein. J Biol Chem 282:353-63.

9. Callison, S. A., T. O. Boynton, D. A. Hilt, and M. W. Jackwood. 2005. Development of microshpere assays for the detection of antibodies against avian pathogens. 142nd AVMA Annual Convention Notes.

10. Canales, R. D., Y. Luo, J. C. Willey, B. Austermiller, C. C. Barbacioru, C. Boysen, K. Hunkapiller, R. V. Jensen, C. R. Knight, K. Y. Lee, Y. Ma, B. Maqsodi, A. Papallo, E. H. Peters, K. Poulter, P. L. Ruppel, R. R. Samaha, L. Shi, W. Yang, L. Zhang, and F. M. Goodsaid. 2006. Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol 24:1115-22.

11. Capua, I., C. Terregino, G. Cattoli, F. Mutinelli, and J. F. Rodriguez. 2003. Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Pathol 32:47-55.

12. Cattoli, G., A. Milani, F. Bettini, M. Serena Beato, M. Mancin, C. Terregino, and I. Capua. 2006. Development and validation of an anti-N3 indirect immunofluorescent antibody test to be used as a companion diagnostic test in the framework of a "DIVA" vaccination strategy for avian influenza infections in poultry. Avian Pathol 35:154-9.

13. Chen, W., P. A. Calvo, D. Malide, J. Gibbs, U. Schubert, I. Bacik, S. Basta, R. O'Neill, J. Schickli, P. Palese, P. Henklein, J. R. Bennink, and J. W. Yewdell. 2001. A novel influenza A virus mitochondrial protein that induces cell death. Nature medicine 7:1306-12.

14. Choi, Y. K., J. H. Lee, G. Erickson, S. M. Goyal, H. S. Joo, R. G. Webster, and R. J. Webby. 2004. H3N2 influenza virus transmission from swine to turkeys, United States. Emerg Infect Dis 10:2156-60.

15. Choi, Y. K., H. Ozaki, R. J. Webby, R. G. Webster, J. S. Peiris, L. Poon, C. Butt, Y. H. Leung, and Y. Guan. 2004. Continuing Evolution of H9N2 Influenza Viruses in Southeastern China. J Virol 78:8609-14.

16. Claas, E. C. 2000. Pandemic influenza is a zoonosis, as it requires introduction of avian-like gene segments in the human population. Vet Microbiol 74:133-9.

17. Clavijo, A., D. B. Tresnan, R. Jolie, and E. M. Zhou. 2002. Comparison of embryonated chicken eggs with MDCK cell culture for the isolation of swine influenza virus. Can J Vet Res 66:117-21.

18. Coleman, J. R. 2007. The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages. Virol J 4:9.

19. Davison, S., A. F. Ziegler, and R. J. Eckroade. 1998. Comparison of an antigen-capture enzyme immunoassay with virus isolation for avian influenza from field samples. Avian Dis 42:791-5.

20. de Jong, M. D., C. P. Simmons, T. T. Thanh, V. M. Hien, G. J. Smith, T. N. Chau, D. M. Hoang, N. V. Chau, T. H. Khanh, V. C. Dong, P. T. Qui, B. V. Cam, Q. Ha do, Y. Guan, J. S. Peiris, N. T. Chinh, T. T. Hien, and J. Farrar. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12:1203-7.

21. De Marco, M. A., E. Foni, L. Campitelli, M. Delogu, E. Raffini, C. Chiapponi, G. Barigazzi, P. Cordioli, L. Di Trani, and I. Donatelli. 2005. Influenza virus circulation in wild aquatic birds in Italy during H5N2 and H7N1 poultry epidemic periods (1998 to 2000). Avian Pathol 34:480-5.

22. Denyer, M. S., and J. R. Crowther. 1986. Use of indirect and competitive ELISAs to compare isolates of equine influenza A virus. J Virol Methods 14:253-65.

23. Deregt, D., T. L. Furukawa-Stoffer, K. L. Tokaryk, J. Pasick, K. M. Hughes, K. Hooper-McGrevy, S. Baxi, and M. K. Baxi. 2006. A microsphere immunoassay for detection of antibodies to avian influenza virus. J Virol Methods 137:88-94.

24. Gao, W., A. C. Soloff, X. Lu, A. Montecalvo, D. C. Nguyen, Y. Matsuoka, P. D. Robbins, D. E. Swayne, R. O. Donis, J. M. Katz, S. M. Barratt-Boyes, and A. Gambotto. 2006. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 80:1959-64.

25. Gibbs, J. S., D. Malide, F. Hornung, J. R. Bennink, and J. W. Yewdell. 2003. The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol 77:7214-24.

26. Guan, Y., K. F. Shortridge, S. Krauss, P. S. Chin, K. C. Dyrting, T. M. Ellis, R. G. Webster, and M. Peiris. 2000. H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J Virol 74:9372-80.

27. Halvorson, D. A. 2002. The control of H5 or H7 mildly pathogenic avian influenza: a role for inactivated vaccine. Avian Pathol 31:5-12.

28. Hinshaw, V. S., R. G. Webster, W. J. Bean, J. Downie, and D. A. Senne. 1983. Swine influenza-like viruses in turkeys: potential source of virus for humans? Science 220:206-8.

29. Horimoto, T., and Y. Kawaoka. 1997. Biologic effects of introducing additional basic amino acid residues into the hemagglutinin cleavage site of a virulent avian influenza virus. Virus Res 50:35-40.

30. Horimoto, T., and Y. Kawaoka. 1994. Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. J Virol 68:3120-8.

31. Huang, Z., S. Elankumaran, A. Panda, and S. K. Samal. 2003. Recombinant Newcastle disease virus as a vaccine vector. Poult Sci 82:899-906.

32. Huang, Z., S. Elankumaran, A. S. Yunus, and S. K. Samal. 2004. A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J Virol In Press.

33. Hulse-Post, D. J., K. M. Sturm-Ramirez, J. Humberd, P. Seiler, E. A. Govorkova, S. Krauss, C. Scholtissek, P. Puthavathana, C. Buranathai, T. D. Nguyen, H. T. Long, T. S. Naipospos, H. Chen, T. M. Ellis, Y. Guan, J. S. Peiris, and R. G. Webster. 2005. Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci U S A 102:10682-7.

34. Karasin, A. I., J. Landgraf, S. Swenson, G. Erickson, S. Goyal, M. Woodruff, G. Scherba, G. Anderson, and C. W. Olsen. 2002. Genetic characterization of H1N2 influenza A viruses isolated from pigs throughout the United States. J Clin Microbiol 40:1073-9.

35. Kawaoka, Y., A. Nestorowicz, D. J. Alexander, and R. G. Webster. 1987. Molecular analyses of the hemagglutinin genes of H5 influenza viruses: origin of a virulent turkey strain. Virology 158:218-27.

36. Kawaoka, Y., and R. G. Webster. 1988. Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc Natl Acad Sci U S A 85:324-8.

37. Kellar, K. L., and M. A. Iannone. 2002. Multiplexed microsphere-based flow cytometric assays. Exp Hematol 30:1227-37.

38. Kern, D., M. Collins, T. Fultz, J. Detmer, S. Hamren, J. J. Peterkin, P. Sheridan, M. Urdea, R. White, T. Yeghiazarian, and J. Todd. 1996. An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 34:3196-202.

39. Lamb, R. A. 1989. Genes and proteins of the influenza viruses. In R. M. Krug (ed.), The influenza viruses, 1st ed. Plenum Press, New York.

40. Landolt, G. A., A. I. Karasin, L. Phillips, and C. W. Olsen. 2003. Comparison of the pathogenesis of two genetically different H3N2 influenza A viruses in pigs. J Clin Microbiol 41:1936-41.

41. Lee, C. W., D. A. Senne, and D. L. Suarez. 2004. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza. Vaccine 22:3175-81.

42. Lin, Y. P., M. Shaw, V. Gregory, K. Cameron, W. Lim, A. Klimov, K. Subbarao, Y. Guan, S. Krauss, K. Shortridge, R. Webster, N. Cox, and A. Hay. 2000. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci U S A 97:9654-8.

43. Lopez, C. B., A. Garcia-Sastre, B. R. Williams, and T. M. Moran. 2003. Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses. J Infect Dis 187:1126-36.

44. Ludwig, S., A. Haustein, E. F. Kaleta, and C. Scholtissek. 1994. Recent influenza A (H1N1) infections of pigs and turkeys in northern Europe. Virology 202:281-6.

45. Makarova, N. V., H. Ozaki, H. Kida, R. G. Webster, and D. R. Perez. 2003. Replication and transmission of influenza viruses in Japanese quail. Virology 310:8-15.

46. Mannam, P., K. F. Jones, and B. L. Geller. 2004. Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes. Infect Immun 72:3444-50.

47. Mayo, M. S., and M. D. Conerly. 1999. Evaluating overall significance levels in multifactor ANOVA. J Biopharm Stat 9:129-43.

48. Mazzoni, A., and D. M. Segal. 2004. Controlling the Toll road to dendritic cell polarization. J. Leukoc. Biol. 75:721-730.

49. Mercenier, A., H. Muller-Alouf, and C. Grangette. 2000. Lactic acid bacteria as live vaccines. Curr Issues Mol Biol 2:17-25.

50. Mohan, R., Y. M. Saif, G. A. Erickson, G. A. Gustafson, and B. C. Easterday. 1981. Serologic and epidemiologic evidence of infection in turkeys with an agent related to the swine influenza virus. Avian Dis 25:11-6.

51. Naeem, K., A. Ullah, R. J. Manvell, and D. J. Alexander. 1999. Avian influenza A subtype H9N2 in poultry in Pakistan. Vet Rec 145:560.

52. Neumann, G., and Y. Kawaoka. 2001. Reverse genetics of influenza virus. Virology 287:243-50.

53. Neumann, G., T. Watanabe, H. Ito, S. Watanabe, H. Goto, P. Gao, M. Hughes, D. R. Perez, R. Donis, E. Hoffmann, G. Hobom, and Y. Kawaoka. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. U S A. 96:9345-9350.

54. Ninomiya, A., A. Takada, K. Okazaki, K. F. Shortridge, and H. Kida. 2002. Seroepidemiological evidence of avian H4, H5, and H9 influenza A virus transmission to pigs in southeastern China. Vet Microbiol 88:107-14.

55. OIE. 2004. Chapter 2.1.14. Highly Pathogenic Avian Influenza, p. 1-12, OIE Terrestrial Manual.

56. Olsen, C. W. 2002. The emergence of novel swine influenza viruses in North America. Virus Res 85:199-210.

57. Olsen, C. W., A. Karasin, and G. Erickson. 2003. Characterization of a swine-like reassortant H1N2 influenza virus isolated from a wild duck in the United States. Virus Res 93:115-21.

58. Palese, P., C. F. Basler, and A. Garcia-Sastre. 2002. The makings of a killer. Nat Med 8:927-8.

59. Parkin, N. T., P. Chiu, and K. Coelingh. 1997. Genetically engineered live attenuated influenza A virus vaccine candidates. J Virol 71:2772-8.

60. Peiris, J. S., Y. Guan, D. Markwell, P. Ghose, R. G. Webster, and K. F. Shortridge. 2001. Cocirculation of avian H9N2 and contemporary "human" H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment? J Virol 75:9679-86.

61. Perez, D. R., W. Lim, J. P. Seiler, G. Yi, M. Peiris, K. F. Shortridge, and R. G. Webster. 2003. Role of quail in the interspecies transmission of H9 influenza A viruses: molecular changes on HA that correspond to adaptation from ducks to chickens. J Virol 77:3148-56.

62. Perez, D. R., R. J. Webby, E. Hoffmann, and R. G. Webster. 2003. Land-based birds as potential disseminators of avian mammalian reassortant influenza A viruses. Avian Dis 47:1114-7.

63. Pickering, J. W., T. B. Martins, M. C. Schroder, and H. R. Hill. 2002. Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for auantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae Type b. Clin Diagn Lab Immunol 9:872-6.

64. Raha, A. R., N. R. Varma, K. Yusoff, E. Ross, and H. L. Foo. 2005. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine. Appl Microbiol Biotechnol 68:75-81.

65. Ramshaw, I. A., A. J. Ramsay, G. Karupiah, M. S. Rolph, S. Mahalingam, and J. C. Ruby. 1997. Cytokines and immunity to viral infections. Immunol Rev 159:119-35.

66. Reis e Sousa, C. 2004. Activation of dendritic cells: translating innate into adaptive immunity. . Curr. Opin. Immunol. 16:21-25.

67. Reis e Sousa, C. 2004. Toll-like receptors and dendritic cells: for whom the bug tolls. Sem. Immunol. 16:27-34.

68. Rott, R., H. D. Klenk, Y. Nagai, and M. Tashiro. 1995. Influenza viruses, cell enzymes, and pathogenicity. Am J Respir Crit Care Med 152:S16-9.

69. Saito, T., W. Lim, T. Suzuki, Y. Suzuki, H. Kida, S. I. Nishimura, and M. Tashiro. 2001. Characterization of a human H9N2 influenza virus isolated in Hong Kong. Vaccine 20:125-33.

70. Scavone, P., A. Miyoshi, A. Rial, A. Chabalgoity, P. Langella, V. Azevedo, and P. Zunino. 2007. Intranasal immunisation with recombinant Lactococcus lactis displaying either anchored or secreted forms of Proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonisation in mice. Microbes Infect 9:821-8.

71. Scholtissek, C. 1997. Molecular epidemiology of influenza. Arch Virol Suppl 13:99-103.

72. Scholtissek, C., and B. R. Murphy. 1978. Host range mutants of an influenza A virus. Arch Virol 58:323-33.

73. Shafer, A. L., J. B. Katz, and K. A. Eernisse. 1998. Development and validation of a competitive enzyme-linked immunosorbent assay for detection of type A influenza antibodies in avian sera. Avian Dis 42:28-34.

74. Shi, Z., M. Zeng, G. Yang, F. Siegel, L. J. Cain, K. van Kampen, C. A. Elmets, and D.-C. Tang. 2001. Protection against Tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines. J Virol 75:11474-11482.

75. Shortridge, K. F. 1992. Pandemic influenza: a zoonosis? Semin Respir Infect 7:11-25.

76. Shortridge, K. F., N. N. Zhou, Y. Guan, P. Gao, T. Ito, Y. Kawaoka, S. Kodihalli, S. Krauss, D. Markwell, K. G. Murti, M. Norwood, D. Senne, L. Sims, A. Takada, and R. G. Webster. 1998. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 252:331-42.

77. Slemons, R. D., and B. C. Easterday. 1977. Type-A influenza viruses in the feces of migratory waterfowl. J Am Vet Med Assoc 171:947-8.

78. Solorzano, A., R. J. Webby, K. M. Lager, B. H. Janke, A. Garcia-Sastre, and J. A. Richt. 2005. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J Virol 79:7535-43.

79. Spackman, E., D. A. Senne, T. J. Myers, L. L. Bulaga, L. P. Garber, M. L. Perdue, K. Lohman, L. T. Daum, and D. L. Suarez. 2002. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 40:3256-60.

80. Starick, E., O. Werner, H. Schirrmeier, B. Kollner, R. Riebe, and E. Mundt. 2006. Establishment of a competitive ELISA (cELISA) system for the detection of influenza A virus nucleoprotein antibodies and its application to field sera from different species. J Vet Med B Infect Dis Vet Public Health 53:370-5.

81. Stebbing, N., and C. A. Grantham. 1976. Anti-viral activity against encephalomyocarditis virus and Semliki Forest virus and acute toxicity of poly I and poly C administered sequentially to mice. Arch Virol 51:199-215.

82. Steinhauer, D. A. 1999. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258:1-20.

83. Suarez, D. L. 2005. Overview of avian influenza DIVA test strategies. Biologicals 33:221-6.

84. Subbarao, E. K., E. J. Park, C. M. Lawson, A. Y. Chen, and B. R. Murphy. 1995. Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine. J Virol 69:5969-77.

85. Subbarao, K., H. Chen, D. Swayne, L. Mingay, E. Fodor, G. Brownlee, X. Xu, X. Lu, J. Katz, N. Cox, and Y. Matsuoka. 2003. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305:192-200.

86. Swayne, D. E., J. R. Beck, and T. R. Mickle. 1997. Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus. Avian Dis 41:910-22.

87. Swayne, D. E., J. R. Beck, M. L. Perdue, and C. W. Beard. 2001. Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza. Avian Dis 45:355-65.

88. Swayne, D. E., M. Garcia, J. R. Beck, N. Kinney, and D. L. Suarez. 2000. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18:1088-95.

89. Swayne, D. E., and D. L. Suarez. 2000. Highly pathogenic avian influenza. Rev Sci Tech 19:463-82.

90. Takada, A., N. Kuboki, K. Okazaki, A. Ninomiya, H. Tanaka, H. Ozaki, S. Itamura, H. Nishimura, M. Enami, M. Tashiro, K. F. Shortridge, and H. Kida. 1999. Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic. J Virol 73:8303-7.

91. Tang, Y., C. W. Lee, Y. Zhang, D. A. Senne, R. Dearth, B. Byrum, D. R. Perez, D. L. Suarez, and Y. M. Saif. 2005. Isolation and characterization of H3N2 influenza A virus from turkeys. Avian Dis 49:207-13.

92. Tollis, M., and L. Di Trani. 2002. Recent developments in avian influenza research: epidemiology and immunoprophylaxis. Vet J 164:202-15.

93. Toro, H., D. C. Tang, D. L. Suarez, M. J. Sylte, J. Pfeiffer, and K. R. Van Kampen. 2007. Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector. Vaccine 25:2886-91.

94. Vignali, D. A. 2000. Multiplexed particle-based flow cytometric assays. J Immunol Methods 243:243-55.

95. Walker, J. A., and Y. Kawaoka. 1993. Importance of conserved amino acids at the cleavage site of the haemagglutinin of a virulent avian influenza A virus. J Gen Virol 74 ( Pt 2):311-4.

96. Wan, H., and D. R. Perez. 2007. Amino acid 226 in the hemagglutinin of H9N2 influenza viruses determines cell tropism and replication in human airway epithelial cells. J Virol 81:5181-91.

97. Wan, H., and D. R. Perez. 2006. Quail carry sialic acid receptors compatible with binding of avian and human influenza viruses. Virology 346:278-86.

98. Waner, J. L., S. J. Todd, H. Shalaby, P. Murphy, and L. V. Wall. 1991. Comparison of Directigen FLU-A with viral isolation and direct immunofluorescence for the rapid detection and identification of influenza A virus. J Clin Microbiol 29:479-82.

99. Wang, X., M. Li, H. Zheng, T. Muster, P. Palese, A. A. Beg, and A. Garcia-Sastre. 2000. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 74:11566-73.

100. Webby, R. J., D. R. Perez, J. S. Coleman, Y. Guan, J. H. Knight, E. A. Govorkova, L. R. McClain-Moss, J. S. Peiris, J. E. Rehg, E. I. Tuomanen, and R. G. Webster. 2004. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 363:1099-103.

101. Webby, R. J., S. L. Swenson, S. L. Krauss, P. J. Gerrish, S. M. Goyal, and R. G. Webster. 2000. Evolution of swine H3N2 influenza viruses in the United States. J Virol 74:8243-51.

102. Webby, R. J., and R. G. Webster. 2001. Emergence of influenza A viruses. Philos Trans R Soc Lond B Biol Sci 356:1817-28.

103. Webster, R. G., W. J. Bean, O. T. Gorman, T. M. Chambers, and Y. Kawaoka. 1992. Evolution and ecology of influenza A viruses. Microbiol Rev 56:152-79.

104. Wells, J. M., K. Robinson, L. M. Chamberlain, K. M. Schofield, and R. W. Le Page. 1996. Lactic acid bacteria as vaccine delivery vehicles. Antonie Van Leeuwenhoek 70:317-30.

105. WHO. 2002. WHO Manual on Animal Influenza Diagnosis and Surveillance, vol. WHO/CDS/CSR/NCS/2002.5. Department of Communicable Disease Surveillance and Response WHO Global Influenza Programme.

106. Wood, J. M., Y. Kawaoka, L. A. Newberry, E. Bordwell, and R. G. Webster. 1985. Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A/Chicken/Pennsylvania/1370/83 infection. Avian Dis 29:867-72.

107. Wright, S. M., Y. Kawaoka, G. B. Sharp, D. A. Senne, and R. G. Webster. 1992. Interspecies transmission and reassortment of influenza A viruses in pigs and turkeys in the United States. Am J Epidemiol 136:488-97.

108. Xu, C., W. Fan, R. Wei, and H. Zhao. 2004. Isolation and identification of swine influenza recombinant A/Swine/Shandong/1/2003(H9N2) virus. Microbes Infect 6:919-25.

109. Yewdell, J., and A. Garcia-Sastre. 2002. Influenza virus still surprises. Curr Opin Microbiol 5:414-8.

110. Zamarin, D., M. B. Ortigoza, and P. Palese. 2006. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 80:7976-83.

111. Zarember, K. A., and P. J. Godowski. 2002. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol 168:554-561.

112. Zell, R., A. Krumbholz, A. Eitner, R. Krieg, K. J. Halbhuber, and P. Wutzler. 2007. Prevalence of PB1-F2 of influenza A viruses. J Gen Virol 88:536-46.

113. Zhou, E. M., M. Chan, R. A. Heckert, J. Riva, and M. F. Cantin. 1998. Evaluation of a competitive ELISA for detection of antibodies against avian influenza virus nucleoprotein. Avian Dis 42:517-22.

114. Zhou, N. N., D. A. Senne, J. S. Landgraf, S. L. Swenson, G. Erickson, K. Rossow, L. Liu, K. Yoon, S. Krauss, and R. G. Webster. 1999. Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J Virol 73:8851-6.

< Back
INTRODUCTION